Related Experiment Video
Updated: Jul 27, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
YY1/miR-140-5p/Jagged1/Notch axis mediates cartilage progenitor/stem cells fate reprogramming in knee osteoarthritis
Yang Chen1, Guangneng Liao2, Ting Ma3
1Department of Orthopedic Surgery & Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Abstract:
Osteoarthritis is a multifactorial disease characterized by cartilage degeneration, while cartilage progenitor/stem cells (CPCs) are responsible for endogenous cartilage repair. However, the relevant regulatory mechanisms of CPCs fate reprogramming in OA are rarely reported. Recently, we observed fate disorders in OA CPCs and found that microRNA-140-5p (miR-140-5p) protects CPCs from fate changes in OA. This study further mechanistically investigated the upstream regulator and downstream effectors of miR-140-5p in OA CPCs fate reprogramming. As a result, luciferase reporter assay and validation assays revealed that miR-140-5p targets Jagged1 and inhibits Notch signaling in human CPCs, and the loss-/gain-of-function experiments and rescue assays discovered that miR-140-5p improves OA CPCs fate, but this effect can be counteracted by Jagged1. Moreover, increased transcription factor Ying Yang 1 (YY1) was associated with OA progression, and YY1 could disturb CPCs fate via transcriptionally repressing miR-140-5p and enhancing the Jagged1/Notch signaling. Finally, the relevant changes and mechanisms of YY1, miR-140-5p, and Jagged1/Notch signaling in OA CPCs fate reprogramming were validated in rats. Conclusively, this study identified a novel YY1/miR-140-5p/Jagged1/Notch signaling axis that mediates OA CPCs fate reprogramming, wherein YY1 and Jagged1/Notch signaling exhibits an OA-stimulative role, and miR-140-5p plays an OA-protective effect, providing attractive targets for OA therapeutics.
Insights
This study reveals a new pathway involving YY1, miR-140-5p, and Jagged1/Notch signaling that controls cartilage stem cell changes in osteoarthritis. Targeting this axis may offer new osteoarthritis treatments.
Area of Science:
- Regenerative Medicine
- Molecular Biology
- Osteoarthritis Pathogenesis
Background:
- Osteoarthritis (OA) involves cartilage degeneration, with cartilage progenitor/stem cells (CPCs) crucial for repair.
- Regulatory mechanisms governing CPC fate in OA remain largely unknown.
- MicroRNA-140-5p (miR-140-5p) has emerged as a potential protector of CPCs in OA.
Purpose of the Study:
- To elucidate the upstream regulators and downstream effectors of miR-140-5p in OA CPC fate reprogramming.
- To investigate the role of the transcription factor Ying Yang 1 (YY1) and the Jagged1/Notch signaling pathway in OA CPCs.
Main Methods:
- Luciferase reporter assays to identify miR-140-5p targets.
- Loss- and gain-of-function experiments in human CPCs.
- Validation of molecular mechanisms in a rat OA model.
Main Results:
- miR-140-5p directly targets Jagged1, inhibiting Notch signaling in human CPCs.
- miR-140-5p promotes healthy CPC fate, an effect reversed by Jagged1.
- Increased YY1 represses miR-140-5p and enhances Jagged1/Notch signaling, contributing to OA progression.
Conclusions:
- A novel YY1/miR-140-5p/Jagged1/Notch signaling axis regulates OA CPC fate reprogramming.
- YY1 and Jagged1/Notch signaling promote OA, while miR-140-5p offers protection.
- This axis presents potential therapeutic targets for osteoarthritis.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Bone Formation by Endochondral Ossification
Mesenchymal Stem Cells
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
TGF - β Signaling Pathway
Bone Remodeling

